Cutting-edge diagnostics

Following the splash that CRISPR has made in the world of therapeutics, academics are expanding the tool kit of Cas enzymes and finding new uses in diagnostics. Early hints suggest the technology could become competitive, and might jump ahead of sequencing methods now at the forefront.

While it’s still early days, the biggest opportunities likely lie in faster and cheaper companion diagnostics for cancer therapies, and point-of-care readouts for infectious diseases. ...